Aktiesnakken — Januar 2011
-
-
Sydbank sætter analysedækningen af Genmab og Neurosearch i bero
http://npinvestor.dk/nyheder/sydbank-saetter-analysedaekningen-af-genmab-og-neurosearch-i-bero-218924.aspx -
Hvad skulle være den gode nyhed om genmab
-
tror først det sker først i marts
-
tror kursen skal ned under 60
-
nu har de sænket kursmål fra 105 til 85
-
se nyheder
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind